Sign up for free insights newsletter
68

Shanghai Haohai Biological Tech Co

688366SHG

Need professional-grade analysis? Visit stockanalysis.com

CN¥39.10
-0.26%
End of day
Market Cap

$8.81B

P/E Ratio

36.11

Employees

2,156

Dividend Yield

2.55%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino4.820.21-2.14-1.72-0.99
Calmar1.10-1.48-0.80-0.70
Sharpe2.520.13-1.71-1.30-0.88
Omega1.811.050.670.770.87
Martin88.391.79-2.79-1.766.00
Ulcer0.131.9514.1115.3011.41

Shanghai Haohai Biological Tech Co (688366) Price Performance

Shanghai Haohai Biological Tech Co (688366) trades on SHG in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY39.10, down 0.26% from the previous close.

Over the past year, 688366 has traded between a low of CNY38.28 and a high of CNY57.62. The stock has lost 26.7% over this period. It is currently 32.1% below its 52-week high.

Shanghai Haohai Biological Tech Co has a market capitalization of $8.81B, with a price-to-earnings ratio of 36.11 and a dividend yield of 2.55%.

About Shanghai Haohai Biological Tech Co

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, the United States, and internationally. The company offers ophthalmic implants, assistive devices, and medical devices; medical optical instruments, including intraocular lenses, endoscopic equipment, ophthalmic surgical instruments, and other ophthalmic medical products; hyaluronic acid and chitosan; and electronic instruments, such as semiconductors, optoelectronics, lasers, radio frequency, and ultrasonic instruments. It also engages in the research and development of biological engineering and pharmaceutical products and related technology transfer activities, consulting, and other services; research, development, production, and sales of radio frequency instruments; cell technology and biochemical product technology research and development; computer, communication, and other electronic equipment manufacturing; instrument manufacturing; manufacture and sale of biological reagents, biological agents, and biological materials; medical-grade sodium hyaluronate bio-based skincare products; intraocular lens and related products; intraocular lens injectors and materials, equipment, chemical products, and accessories for contact lenses and artificial lenses; sale of ophthalmology products; and provision of other machines and accessories. In addition, the company is involved in property management; business management consulting; non-residential real estate leasing; provision of technical services, technology promotion, development and transfer, technical consulting and exchange; wholesale of cosmetics; import and export of goods; import and export of technology; and information technology consulting services. The company was formerly known as Haohai Limited and changed its name to Shanghai Haohai Biological Technology Co., Ltd. in 2010. The company was founded in 2007 and is headquartered in Shanghai, China.

Compare Shanghai Haohai Biological Tech Co

Side-by-side comparison against top Healthcare peers.

Company Info

Exchange
SHG
Currency
CNY
Country
China

Financial Metrics

Revenue (TTM)
$2.45B
EBITDA
$442.73M
Profit Margin
10.26%
EPS (TTM)
1.08
Book Value
23.98

Technical Indicators

52 Week High
CN¥58.97
52 Week Low
CN¥37.80
50 Day MA
CN¥42.41
200 Day MA
CN¥48.56
Beta
0.59

Valuation

Trailing P/E
36.11
Forward P/E
39.68
Price/Sales
3.60
Price/Book
1.63
Enterprise Value
$6.01B